Home » Newsletters » BioWorld Science

BioWorld Science

June 24, 1999

View Archived Issues

Synsorb Biotech licenses potential cystic fibrosis therapies

MiniMed enters collaboration with Elan for Medipad drug delivery system

Copley launches first controlled drug

Company Profile: Probiodrug

Cell Pathways completes phase III APC trial analysis

Amarillo Biosciences reaches IFN-alpha development agreement in China

Two gene therapy clinical trials under way for coronary artery disease

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

FDA approves new glucose monitoring system

Solvay announces commencement of tender offer to acquire Unimed

Gliatech presents results of new antiinflammation program

Immune Response implements restructuring plan

Avant receives approval to conduct clinical trial of atherosclerosis vaccine

CLX-0901: a novel compound for the treatment of type II diabetes

Calyx scientists identify CLX-0301, a novel antidiabetic and candidate for clinical testing

Takeda presents new compounds for asthma, allergic disorders

Ion and collaborators focus efforts on sickle cell disease and proliferative disorders

Erythromycin derivatives prepared under Taisho-Sagami collaboration

AM-6898E: new anti-IgE antibody agent for immune disorders

Does melatonin improve the tolerability of chemotherapy?

Antidiabetic activity and mechanism of action of R-102380, a novel TZD from Sankyo

Early indications of antidiabetic potential for adenosine A1 agonist from Glaxo Wellcome

Potential new use for donepezil: Rx of dyskinesias and other symptoms in IPD

CRF1 receptor antagonist may be beneficial in stress-induced psychosomatic disorders

GlycoDesign expands GD0039 phase II cancer trial to additional site

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....